
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Introduction: Looking Beyond the Formulary Budget
Author(s)Gary L. Viale, PharmD
Advertisement
Articles in this issue
about 29 years ago
Evaluating the Cost Effectiveness of Newer Psychotropic Medicationsabout 29 years ago
Looking Beyond the Formulary Budget in Cost-Benefit Analysisabout 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomeabout 29 years ago
Newer Antipsychotic Medications: Discussionsabout 29 years ago
Bibliographyabout 29 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency
2
New Regulations on PBMs Become Law: What This Means for Pharmacies Nationwide—A Q&A With Jesse Dresser, Esq
3
Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs
4
Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries
5








